Cytotec (Misoprostol) for Medical Abortion: Protocol, Efficacy & Safety

Misoprostol (brand Cytotec) is a prostaglandin E₁ analogue used for medical abortion up to 12 weeks' gestation (often up to 13 weeks per WHO). It is not FDA-approved for this indication in the US but is standard of care globally and used off-label.

Standard Regimen (Combined with Mifepristone)

  1. Mifepristone 200 mg PO – Blocks progesterone, primes cervix, sensitizes uterus to prostaglandins.
  2. 24–48 hours later: Misoprostol 800 mcg buccal/vaginal/sublingual – Induces uterine contractions and cervical ripening.

Misoprostol-Only Regimen (Where Mifepristone Unavailable)

  • 800 mcg buccal/vaginal/sublingual every 3–12 hours × 2–3 doses.
  • Lower efficacy (~85–90% vs. 95–98% combined).

Efficacy & Timeline

  • Complete expulsion: ~95% with combined regimen.
  • Onset: Bleeding/cramping typically within 1–4 hours post-misoprostol.
  • Expulsion: Often within 6–24 hours; may take longer.

Common Side Effects

  • Heavy bleeding (may exceed normal period), cramping, nausea, vomiting, diarrhea, fever/chills (transient, usually <24 hrs), headache.

Serious Complications (Rare)

  • Uterine rupture – Higher risk with prior uterine surgery (C-section, myomectomy); contraindicated in some guidelines.
  • Incomplete abortion – Retained products → prolonged bleeding, infection; may need suction curettage.
  • Hemorrhage – Requiring transfusion (<0.1%).
  • Sepsis – Rare; monitor for sustained fever, foul discharge, hemodynamic instability.

Contraindications / Cautions

  • Confirmed/suspected ectopic pregnancy.
  • IUD in situ (remove first).
  • Chronic adrenal failure, inherited porphyria, anticoagulation/bleeding disorders.
  • Allergy to misoprostol or prostaglandins.

Medical supervision is mandatory. Follow-up (clinical ± ultrasound ± hCG) at 1–2 weeks confirms completion.

Pregnancy & Health - Related Articles